Novagali Pharma completes second financing round of 14.2 million euros
Novagali Pharma will use new funds for clinical trials of its ophthalmic products and to develop new applications for its innovative technology
21-Sep-2004 -
Evry, France. Novagali Pharma, a drug delivery
specialist using cationic emulsions to address ophthalmic and other
applications including oncology, announces today the completion of its
second round of financing. The total amount raised is EUR 14.2 million.
New investors Edmond de Rothschild ...
chemotherapy
clinical trials
diseases
+5